Capital expenditure, investment, and financing will cumulatively reach ¥240 billion between fiscal years 2014 and 2016. This is about ¥60 billion higher than the cumulative total for the previous three years. For the current three-year period, there will be concentrated investment of ¥100 billion in the first year, fiscal year 2014. The Business Technologies Business will make ongoing investment in molds, systems, and the like as part of new product development. Now it will also be actively investing in IT services and M&A that will expand solutions sales. In the Healthcare Business, we are working to strengthen medical IT, which we see as a growth field. However, the percentage of our sales taking place outside Japan is only about 50%, which is not enough. Outside Japan, our sales and service infrastructure is not as developed as in Japan. Going forward, we will not only be developing sales channels but also considering M&A to strengthen medical IT. The Industrial Business is studying potential new domains for its sensing devices business.